Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/2/2020
SIETES contiene 92916 citas

 
 
 1 a 20 de 93 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Wallach JD, Wang K, Zhang AD, Cheng D, Grossetta Nardini HK, Lin H, Bracken MB, Desai M, Krumholz HM, Ross JS. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. BMJ 2020;368:5 de febrero. [Ref.ID 103514]
2.Enlace a cita original Cita con resumen
Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen RJ, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:24 de octubre. [Ref.ID 103199]
4.Enlace a cita original Cita con resumen
Ross JS, Krumholz HM, Hines Jr HH. Bringing Vioxx back to market. BMJ 2018;360:k242. [Ref.ID 102639]
5. Cita con resumen
Pease AM, Krumholz HM, Hines HH, Downing NS, Aminawung JA, Shah ND, Ross JS. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review. BMJ 2017;357:j1680. [Ref.ID 101573]
6. Cita con resumen
Downing NS, Shah ND, Aminawung JA, Pease AM, Zeitoun JD, Krumholz HM, Ross JS. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 2017;317:1854-63. [Ref.ID 101567]
7. Cita con resumen
Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, Inzucchi SE, Gill TM, Krumholz HM, Shah ND. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 2017;40:468-75. [Ref.ID 101507]
8. Cita con resumen
Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, Inzucchi SE, Gill TM, Krumholz HM, Shah ND. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 2016:septiembre. [Ref.ID 100915]
9.Enlace a cita original
Krumholz HM, Waldstreicher J. The Yale Open Data Access (YODA) project - A mechanism for data sharing. N Engl J Med 2016;375:403-5. [Ref.ID 100703]
10. Cita con resumen
Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, Brown D, Ross JS. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. BMJ 2016;354:i4189. [Ref.ID 100605]
11. Cita con resumen
Chen R, Desai NR, Ross JS, Zhang W, Chau KH, Wayda B, Murugiah K, Lu DY, Mittal A, Krumholz HM, Hines HH. Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. BMJ 2016;352:i637. [Ref.ID 100065]
12.Tiene citas relacionadas Cita con resumen
Krumholz HM, Peterson ED. Open access to clinical trials data . JAMA 2014;312:1002-3. [Ref.ID 97950]
13. Cita con resumen
Ross JS, Frazee SG, Garavaglia SB, Levin R, Novshadian H, Jackevicius CA, Stettin G, Krumholz HM. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. JAMA Intern Med 2014;174:1486-93. [Ref.ID 97900]
14. Cita con resumen
Dharmarajan K, Masoudi FA, Spertus JA, Li SX, Krumholz HM. Contraindicated initiation of ß-blocker therapy in patients hospitalized for heart failure. JAMA Intern Med 2013;173:1547-9. [Ref.ID 96076]
15. Cita con resumen
Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi S, Krumholz HM, Karter AJ. HbA1c and risk of severe hypoglycemia in type 2 diabetes. The Diabetes and Aging Study. Diabetes Care 2013;36:3535-42. [Ref.ID 95844]
16.Tiene citas relacionadas
Krumholz HM, Ross JS, Gross CP, Emanuel EJ, Hodshon B, Ritchie JD, Low JB, Lehman R. A historic moment for open science: the Yale University open data access project and Medtronic. Ann Intern Med 2013;158:910-1. [Ref.ID 95684]
17. Cita con resumen
Krumholz HM, Jackevicius CA, Ross JS. Tamiflu: 14 flu seasons and still questions. BMJ 2013;346:9. [Ref.ID 94927]
18. Cita con resumen
Dhamarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013;309:355-63. [Ref.ID 94798]
19. Cita con resumen
Goldberger ZD, Chan PS, Berg RA, Kronick SL, Cooke CR, Lu M, Banerjee M, Hayward RA, Krumholz HM, Nallamothu BK, for the American Heart Association Get With The Guidelines - Resuscitation (formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet 2012;380:1473-81. [Ref.ID 94318]
20. Cita con resumen
Krumholz HM. Cardiology top stories of 2012. Journal Watch 2012:26 de diciembre. [Ref.ID 93419]
Seleccionar todas
 
 1 a 20 de 93 siguiente >>